A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

NCT04929223 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

542

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Inavolisib
DRUG: Bevacizumab
DRUG: Cetuximab
DRUG: Atezolizumab
DRUG: Tiragolumab
DRUG: SY-5609
DRUG: Divarasib
DRUG: FOLFOX
DRUG: FOLFIRI
DIAGNOSTIC_TEST: FoundationOne®Liquid CDx

Sponsor

Hoffmann-La Roche